Used as an intermediate in pharmaceutical synthesis, particularly in the development of active pharmaceutical ingredients (APIs) requiring constrained cyclohexylamine scaffolds. Its protected amine group allows for selective reactions in multi-step syntheses, making it valuable in creating drugs with improved metabolic stability and target specificity. Commonly employed in the production of kinase inhibitors and central nervous system agents. Also utilized in medicinal chemistry for structure-activity relationship (SAR) studies due to its defined stereochemistry and steric profile.